Spinal cord injury research triggering an immune system response. Animal studies with injection of bone marrow stem cells have shown improvement in motor function; however not so in a human trial a year post-injury. More trials are underway. Adipose and umbilical tissue stem cells need further study before human trials can be performed, but two Korean studies were begun to investigate adipose cells in SCI patients. Transplantation of tissues such as olfactory ensheathing cells from the olfactory bulbs has been shown to produce beneficial effects in spinal cord injured rats. Trials have also begun to show success when olfactory ensheathing cells are transplanted into
Spinal cord injury can also be non-traumatic and caused by disease (transverse myelitis, polio, spina bifida, Friedreich's ataxia, spinal cord tumor, spinal stenosis etc.) In the U.S., 10,000–12,000 people become paralyzed annually as a result of various injuries to the spinal cord. Real or suspected spinal cord injuries need immediate immobilisation including that of the head. Scans will be needed to assess the injury. A steroid, methylprednisolone, can be of help as can physical therapy and possibly antioxidants. Treatments need to focus on limiting post-injury cell death, promoting cell regeneration, and replacing lost cells. Regeneration is facilitated by maintaining electric transmission in